🇺🇸 FDA
Pipeline program

Capox chemotherapy

RC-CT-2021

Phase 3 small_molecule active

Quick answer

Capox chemotherapy for Rectal Cancer is a Phase 3 program (small_molecule) at China SXT Pharmaceuticals with 1 ClinicalTrials.gov record(s).

Program details

Company
China SXT Pharmaceuticals
Indication
Rectal Cancer
Phase
Phase 3
Modality
small_molecule
Status
active

Clinical trials